Schizophrenia - Cost of illness

International Journal of Pharmaceutical Sciences Review and Research

Volumn 6, Issue 1, 2011, Pages 55-59

  Pahuja, Sudeepti ^a   Aboobacker, Shameena ^a   Shini, V K ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cost of Illness; Pharmacoeconomics; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CLINICAL ARTICLE; COST OF ILLNESS; DISEASE SEVERITY; DRUG COST; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH DISPARITY; HOSPITAL COST; HUMAN; HYPERGLYCEMIA; MALE; MEDICAL FEE; OBESITY; SCHIZOPHRENIA; SIDE EFFECT; TERTIARY HEALTH CARE; WEIGHT GAIN;

EID: 79952044224     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bootman LJ, Townsend RJ, McGhan WF, Principles of Pharmacoeoconmics, II Edn., Cincinnati OH: Harvey Whitney Books Co., 1996
2. Revikumar KG, Miglani BD, "Pharmacoeconomics and quality of life", A text book of Pharmacy Practice, 1st Edn, Career Publications, 2009, 443
3. Whiteford H, Teeson M, Scheurer R, Jamison D, "Responding to the burden of mental illness", CMH Working Paper Series, Paper No. WG1:12
4. Buchanan RW, Carpenter WT, "Schizophrenia: An Introduction and Overview, Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 7th Edn, Lippincott Williams & Wilkins Publishers, 2000: 2285
5. Lindstorm E, Jonsson D, Knorring L, "Health Economic Aspects on the Treatment of Schizophrenia", Basel: Karger, International Academy of Biomedical and Drug Research, 1995. 182-92
6. Tripathi KD, Drugs used in mental illness: Antipsychotic and antianxiety drugs, Essentials of Medical Pharmacology, 5th Edn, Jaypee Publications, 2003, 390.
7. Dipiro. JT, Talbert R, Yee GC, Yatzke GR, Wells BG, Posey M, "Pharmacotherapy A Pathophysiologic Approach" 5h edition, Mc Graw Hill Medical Publishers, 1626.
8. Marder SR, "Schizophrenia: Somatic Treatment, Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 7th Edn, Lippincott Williams & Wilkins Publishers, 2000: 2492
9. Ucok A, Gaebel W, Side effects of atypical antipsychotics: a brief overview, WPA Section Report, World Psychiatry 2008;7:58-62
10. Shah A, Jenkins R. Mental Health Economic Studies from developing countries reviewed in context of those from developed coutries. Acta Psyhciatr Scand 2000. 101:87-103
11. Wasylenki DA, "The Cost of Schizophrenia", Can J Psychiatry, November1994, S65-9.
12. Wyatt RJ, Henter I, Leary MC, Taylor E. "An economic evaluation of Schizophrenia". Soc Psychiatry Epidemiol; 1995, 30:196-205
13. Evers S, Ament A, Cost of Schizophrenia in Netherlands. Schizophr Bull. 1995; 21:141-53
14. Llorca PM, Miadi-Fargier H, Lançon C, et al. Costeffectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation. Encephale. 2005 Mar-Apr; 31(2):235-46.
15. Grover S, Avasthi A, Chakrabrty S, Kulahara P. Commentaries on the cost of illness of schizophrenia: overview and emerging trends. Indian J Psychiatry. 2005; 47:205-17
16. Knapp M, Chishlom D, Leese M et al. Comparing patterns of schizophrenia care in five European countries: The EPSILON Study. Acta Psyhciatr Scand. 2002; 105:42-54
17. Salize HS, Rossler W. The cost of comprehensive care of people with schizophrenia living in the community catchment area. Br. J. Psychiatry. 1996; 169:42-8
18. Cuffel BJ, Jeste DB, Halpain M, et al. Treatment costs and use of community mental health services for schizophrenia by age cohorts. Am J Psychiatry. 1996; 153:870-6
19. Georee R, O'Brien BJ, Georing RNP, et al The economic burden of Schizophrenia in Canada. Can J Psychiatry. 1999; 44:464-72
20. Haro JM, Salavador-Carulla L, Madoz V et al. Utilization of mental health services and cost of patients with schizophrenia in three areas of Spain. Br J Psychiatry. 1998; 173: 334-40
21. Brown CS, Markowitz JS, Moore TR, Parker NG, Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs. The Annals of Pharmacotherapy: Vol. 33. 1999 2:210-7
22. Girish K, Pratima M, Isaac MK. Drug treatment in Schizophrenia: Issues of Comparability and cost. Indian J Psychiatry. 1991; 41:100-3
23. McCombs JS, Nichol MB, Johnstone MJ, et al. Antipsychotic Drug Use Patterns and the Cost of Treating Schizophrenia. Psychiatric Services Vol. 51. April 2000; 4:525-7
24. Davies LM, Drummond MF, Economics and schizophrenia: the real cost, Br. J Psychiatry, 1994 165(Suppl: 25): 18-21
25. Rouillon F, Toumi M, Dansette GY, et al. Some aspects of cost of schizophrenia in France. Pharmacoeconomics. 1997; 11:578-94
26. Parthasarthy R, Cost of Illness of Schizophrenia: A community based perspective, Indian Journal of Psychiatry; 2005, 47:205-217
27. Norquist GS, Narrow WE, "Schizophrenia: Epidemiology", Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 7th Edn, Lippincott Williams & Wilkins Publishers, 2000: 2313